Update on Donor Assessment, Resuscitation, and Acceptance Criteria, Including Novel Techniques-Non-Heart-Beating Donor Lung Retrieval and Ex Vivo Donor Lung Perfusion

Thoracic Surgery Clinics

Volumn 19, Issue 2, 2009, Pages 261-274

  Yeung, Jonathan C ^a   Cypel, Marcelo ^a   Waddell, Thomas K ^a   van Raemdonck, Dirk ^b   Keshavjee, Shaf ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Donor assessment; Donor resuscitation; Ex vivo lung perfusion; Lung transplantation; Non heart beating donor

Indexed keywords

DOPAMINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR; VASOPRESSIN;

AIR CONDITIONING; ANTIDIURESIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DONOR SELECTION; DRUG COST; DRUG HALF LIFE; EX VIVO STUDY; EXTRACORPOREAL OXYGENATION; GENE THERAPY; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; IMAGE RETRIEVAL; LUNG PERFUSION; LUNG RESECTION; LUNG TRANSPLANTATION; LUNG VOLUME; MEDICAL SOCIETY; NON HEART BEATING DONOR; ORGAN DONOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; REVIEW; SCORING SYSTEM; SURGICAL APPROACH; SURGICAL TECHNIQUE; TOTAL LUNG CAPACITY;

DONOR SELECTION; HUMANS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; RESPIRATORY FUNCTION TESTS; TISSUE AND ORGAN HARVESTING;

EID: 66249105705     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2009.02.006     Document Type: Review

References (101)

1. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 8 (2007) 782-795
2. Reports UNfOSD. National Data. 2008. Available at: (2008). http://www.unos.org/data/about/viewDataReports.asp Accessed June 24, 2008
3. de Perrot M., Weder W., Patterson G.A., et al. Strategies to increase limited donor resources. Eur Respir J 23 3 (2004) 477-482
4. Kootstra G., Kievit J., and Nederstigt A. Organ donors: heartbeating and non-heartbeating. World J Surg 26 2 (2002) 181-184
5. Steinbrook R. Organ donation after cardiac death. N Engl J Med 357 3 (2007) 209-213
6. Steen S., Sjoberg T., Pierre L., et al. Transplantation of lungs from a non-heart-beating donor. Lancet 357 9259 (2001) 825-829
7. Orens J.B., Boehler A., de Perrot M., et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 22 11 (2003) 1183-1200
8. Arcasoy S.M., Fisher A., Hachem R.R., et al. Report of the ISHLT Working Group on primary lung graft dysfunction part V: predictors and outcomes. J Heart Lung Transplant 24 10 (2005) 1483-1488
9. Ware L.B., Wang Y., Fang X., et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360 9333 (2002) 619-620
10. Kootstra G., Daemen J.H., and Oomen A.P. Categories of non-heart-beating donors. Transplant Proc 27 5 (1995) 2893-2894
11. Hardy J.D., Webb W.R., Dalton Jr. M.L., et al. Lung homotransplantation in man. JAMA 186 (1963) 1065-1074
12. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA 205 6 (1968) 337-340
13. Egan T.M., Lambert Jr. C.J., Reddick R., et al. A strategy to increase the donor pool: use of cadaver lungs for transplantation. Ann Thorac Surg 52 5 (1991) 1113-1120 [discussion: 1120-1]
14. Ulicny Jr. K.S., Egan T.M., and Lambert Jr. C.J. Cadaver lung donors: effect of preharvest ventilation on graft function. Ann Thorac Surg 55 5 (1993) 1185-1191
15. Alessandrini F., D'Armini A.M., Roberts C.S., et al. When does the lung die? II. Ultrastructural evidence of pulmonary viability after "death". J Heart Lung Transplant 13 5 (1994) 748-757
16. D'Armini A.M., Roberts C.S., Griffith P.K., et al. When does the lung die? I. Histochemical evidence of pulmonary viability after "death". J Heart Lung Transplant 13 5 (1994) 741-747
17. Egan T.M. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant 23 1 (2004) 3-10
18. Van Raemdonck D.E., Rega F.R., Neyrinck A.P., et al. Non-heart-beating donors. Semin Thorac Cardiovasc Surg 16 4 (2004) 309-321
19. Love R.B., Stringham J., Chomiak P.N., et al. First successful lung transplantation using a nonheart-beating donor. J Heart Lung Transplant 14 S (1995) S88
20. Love R.B., D'Allesandro A.M., Cornwell R.A., et al. Ten year experience with human lung transplantation from non-heart beating donors. J Heart Lung Transplant 22 1 Suppl 1 (2003) S87
21. Nunez J.R., Varela A., del Rio F., et al. Bipulmonary transplants with lungs obtained from two non-heart-beating donors who died out of hospital. J Thorac Cardiovasc Surg 127 1 (2004) 297-299
22. Gamez P., Cordoba M., Ussetti P., et al. Lung transplantation from out-of-hospital non-heart-beating lung donors. one-year experience and results. J Heart Lung Transplant 24 8 (2005) 1098-1102
23. de Antonio D.G., Marcos R., Laporta R., et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 26 5 (2007) 529-534
24. Erasmus M.E., van der Bij W., and Verschuuren E.A.M. 56: non-heart-beating lung donation in the Netherlands: the first experience. J Heart Lung Transplant 25 2 Suppl 1 (2006) S63
25. Butt T.A., Aitchison J.D., Corris P.A., et al. 140: lung transplantation from deceased donors without pretreatment. J Heart Lung Transplant 26 2, Suppl 1 (2007) S110
26. Oto T., Levvey B., McEgan R., et al. A practical approach to clinical lung transplantation from a Maastricht Category III donor with cardiac death. J Heart Lung Transplant 26 2 (2007) 196-199
27. Van Raemdonck D., Verleden G.M., Dupont L., et al. 382: initial experience with lung transplantation from non-heart-beating donors. J Heart Lung Transplant 27 2, Suppl 1 (2008) S198-S199
28. Steen S., Ingemansson R., Budrikis A., et al. Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg 63 2 (1997) 345-351
29. Rega F.R., Neyrinck A.P., Verleden G.M., et al. How long can we preserve the pulmonary graft inside the nonheart-beating donor?. Ann Thorac Surg 77 2 (2004) 438-444 [discussion: 444]
30. Steen S., Ingemansson R., Eriksson L., et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 83 6 (2007) 2191-2194
31. Van Raemdonck D.E., Jannis N.C., De Leyn P.R., et al. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg 228 6 (1998) 788-796
32. Snell G.I., Levvey B.J., and Williams T.J. Non-heart beating organ donation. Intern Med J 34 8 (2004) 501-503
33. Aigner C., Seebacher G., and Klepetko W. Lung transplantation. Donor selection. Chest Surg Clin N Am 13 3 (2003) 429-442
34. Van De Wauwer C., Neyrinck A., Geudens N., et al. The mode of death in the non-heart-beating donor has an impact on lung graft quality. Interact Cardiovasc Thorac Surg 6 S2 (2007) 199
35. Sohrabi S., Navarro A., Asher J., et al. Agonal period in potential non-heart-beating donors. Transplant Proc 38 8 (2006) 2629-2630
36. Snell G.I., Griffiths A., Levvey B.J., et al. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant 27 6 (2008) 662-667
37. Bhorade S.M., Vigneswaran W., McCabe M.A., et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 19 12 (2000) 1199-1204
38. Botha P., Trivedi D., Weir C.J., et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 131 5 (2006) 1154-1160
39. Gabbay E., Williams T.J., Griffiths A.P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160 1 (1999) 265-271
40. Kron I.L., Tribble C.G., Kern J.A., et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 217 5 (1993) 518-522 [discussion: 522-4]
41. Lardinois D., Banysch M., Korom S., et al. Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg 27 5 (2005) 762-767
42. Pierre A.F., Sekine Y., Hutcheon M.A., et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 123 3 (2002) 421-427 [discussion: 427-8]
43. Sundaresan S., Semenkovich J., Ochoa L., et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 109 6 (1995) 1075-1079 [discussion: 1079-80]
44. Oto T., Levvey B.J., Whitford H., et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 83 1 (2007) 257-263
45. Cypel M., Yildirim E., Boasquevisque C., et al. Donor scoring does not predict early outcome. J Heart Lung Transplant 27 2 (2008) S251
46. de Perrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 4 (2003) 490-511
47. Amado J.A., Lopez-Espadas F., Vazquez-Barquero A., et al. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism 44 6 (1995) 812-816
48. Avlonitis V.S., Fisher A.J., Kirby J.A., et al. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 75 12 (2003) 1928-1933
49. Pratschke J., Wilhelm M.J., Kusaka M., et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 67 3 (1999) 343-348
50. de Perrot M., Sekine Y., Fischer S., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165 2 (2002) 211-215
51. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 163 1 (2001) 259-265
52. Kaneda H., Waddell T.K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 6 3 (2006) 544-551
53. Ray M., Dharmarajan S., Freudenberg J., et al. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 7 10 (2007) 2396-2405
54. Anraku M., Cameron M.J., Waddell T.K., et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 8 10 (2008) 2140-2148
55. Steen S., Liao Q., Wierup P.N., et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 76 1 (2003) 244-252 [discussion: 252]
56. Wierup P., Haraldsson A., Nilsson F., et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 81 2 (2006) 460-466
57. Neyrinck A., Rega F., Jannis N., et al. Ex vivo reperfusion of human lungs declined for transplantation; a novel approach to alleviate donor organ shortage?. J Heart Lung Transplant 23 2 Suppl 1 (2004) S172-S173
58. Brandes H., Albes J.M., Conzelmann A., et al. Comparison of pulsatile and nonpulsatile perfusion of the lung in an extracorporeal large animal model. Eur Surg Res 34 4 (2002) 321-329
59. Hardesty R.L., and Griffith B.P. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg 93 1 (1987) 11-18
60. Egan T.M., Haithcock J.A., Nicotra W.A., et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 81 4 (2006) 1205-1213
61. Erasmus M.E., Fernhout M.H., Elstrodt J.M., et al. Normothermic ex vivo lung perfusion of non-heart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation. Transpl Int 19 7 (2006) 589-593
62. Cypel M., Yeung J., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 27 12 (2008) 1319-1325
63. Cypel M., Hirayama S., Rubacha M., et al. 385:Ex-Vivo Normothermic Lung Perfusion (EVLP) interrupts ischemic injury and restores cellular metabolism. J Heart Lung Transplant 27 2 Suppl 1 (2008) S199-S200
64. Straznicka M., Follette D.M., Eisner M.D., et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 124 2 (2002) 250-258
65. Angel L.F., Levine D.J., Restrepo M.I., et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 174 6 (2006) 710-716
66. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 29 8 (1997) 3770-3772
67. Venkateswaran R.V., Patchell V.B., Wilson I.C., et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 85 1 (2008) 278-286 [discussion: 286]
68. Novitzky D., Wicomb W.N., Rose A.G., et al. Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon. Ann Thorac Surg 43 3 (1987) 288-294
69. Marshall V.C. Pathophysiology of brain death: effects on allograft function. Transplant Proc 33 1-2 (2001) 845-846
70. Linos K., Fraser J., Freeman W.D., et al. Care of the brain-dead organ donor. Curr Anaesth Crit Care 18 5-6 (2007) 284-294
71. Pennefather S.H., Bullock R.E., and Dark J.H. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 56 6 (1993) 1418-1422
72. Shemie S.D., Ross H., Pagliarello J., et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ 174 6 (2006) S13-S32
73. Schnuelle P., Berger S., de Boer J., et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 72 3 (2001) 455-463
74. Mukadam M.E., Harrington D.K., Wilson I.C., et al. Does donor catecholamine administration affect early lung function after transplantation?. J Thorac Cardiovasc Surg 130 3 (2005) 926-927
75. Rostron A.J., Avlonitis V.S., Cork D.M., et al. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation 85 4 (2008) 597-606
76. Pennefather S.H., Bullock R.E., Mantle D., et al. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 59 1 (1995) 58-62
77. Debaveye Y.A., and Van den Berghe G.H. Is there still a place for dopamine in the modern intensive care unit?. Anesth Analg 98 2 (2004) 461-468
78. Follette D.M., Rudich S.M., and Babcock W.D. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 17 4 (1998) 423-429
79. Rosendale J.D., Chabalewski F.L., McBride M.A., et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2 8 (2002) 761-768
80. Ware L.B., Fang X., Wang Y., et al. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 93 5 (2002) 1869-1874
81. Sato M., and Keshavjee S. Gene therapy in lung transplantation. Curr Gene Ther 6 4 (2006) 439-458
82. Tagawa T., Kozower B.D., Kanaan S.A., et al. Tumor necrosis factor inhibitor gene transfer ameliorates lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 126 4 (2003) 1147-1154
83. Tagawa T., Dharmarajan S., Hayama M., et al. Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Ann Thorac Surg 78 6 (2004) 1932-1939 [discussion: 1939]
84. Ugurlu M.M., Griffin M.D., O'Brien T., et al. The effects of CTLA-4Ig on acute lung allograft rejection: a comparison of intrabronchial gene therapy with systemic administration of protein. Transplantation 71 12 (2001) 1867-1871
85. Chang G.J., Liu T., Feng S., et al. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery 132 2 (2002) 149-156
86. de Waal Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 4 (1991) 915-924
87. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170 6 (1989) 2081-2095
88. Moore K.W., de Waal Malefyt R., Coffman R.L., et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
89. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 2 (2003) 241-269
90. Eppinger M.J., Ward P.A., Bolling S.F., et al. Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 112 5 (1996) 1301-1305 [discussion: 1305-6]
91. Fischer S., Liu M., MacLean A.A., et al. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum Gene Ther 12 12 (2001) 1513-1526
92. Itano H., Mora B.N., Zhang W., et al. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation. J Thorac Cardiovasc Surg 122 1 (2001) 29-38
93. Itano H., Zhang W., Ritter J.H., et al. Adenovirus-mediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts. J Thorac Cardiovasc Surg 120 5 (2000) 947-956
94. Itano H., Zhang W., Ritter J.H., et al. Endobronchial transfection of naked viral interleukin-10 gene in rat lung allotransplantation. Ann Thorac Surg 71 4 (2001) 1126-1133
95. de Perrot M., Fischer S., Liu M., et al. Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. Am J Respir Cell Mol Biol 28 5 (2003) 616-625
96. Martins S., de Perrot M., Imai Y., et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther 11 24 (2004) 1786-1796
97. Kanaan S.A., Kozower B.D., Suda T., et al. Intratracheal adenovirus-mediated gene transfer is optimal in experimental lung transplantation. J Thorac Cardiovasc Surg 124 6 (2002) 1130-1136
98. Kozower B.D., Kanaan S.A., Tagawa T., et al. Intramuscular gene transfer of interleukin-10 reduces neutrophil recruitment and ameliorates lung graft ischemia-reperfusion injury. Am J Transplant 2 9 (2002) 837-842
99. Romano G., Michell P., Pacilio C., et al. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18 1 (2000) 19-39
100. Zsengeller Z.K., Wert S.E., Hull W.M., et al. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum Gene Ther 6 4 (1995) 457-467
101. Cypel M., Rubacha M., Hirayama S., et al. 331:ex-vivo repair and regeneration of damaged human donor lungs. J Heart Lung Transplant 27 2 Suppl 1 (2008) S180